These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 15269153)

  • 1. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
    Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
    Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
    Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
    Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of cyclooxygenase (COX)-2 products in acceleration of ulcer healing by gastrin and hepatocyte growth factor.
    Brzozowski T; Konturek PC; Konturek SJ; Pajdo R; Schuppan D; Drozdowicz D; Ptak A; Pawlik M; Nakamura T; Hahn EG
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):751-73. PubMed ID: 11192947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
    Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.
    Morris CD; Armstrong GR; Bigley G; Green H; Attwood SE
    Am J Gastroenterol; 2001 Apr; 96(4):990-6. PubMed ID: 11316217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.
    Wilson KT; Fu S; Ramanujam KS; Meltzer SJ
    Cancer Res; 1998 Jul; 58(14):2929-34. PubMed ID: 9679948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
    Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW
    J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
    Fong LY; Zhang L; Jiang Y; Farber JL
    J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
    Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
    Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 in Barrett's esophagus, Barrett's adenocarcinomas, and esophageal SCC: ready for clinical trials.
    Lord RV; Danenberg KD; Danenberg PV
    Am J Gastroenterol; 1999 Aug; 94(8):2313-5. PubMed ID: 10445576
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
    Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
    Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of inflammation on cyclooxygenase (COX)-2 expression in benign and malignant oesophageal cells.
    Abdalla SI; Sanderson IR; Fitzgerald RC
    Carcinogenesis; 2005 Sep; 26(9):1627-33. PubMed ID: 15878911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma.
    Jiménez P; Piazuelo E; Cebrian C; Ortego J; Strunk M; García-Gonzalez MA; Santander S; Alcedo J; Lanas A
    Aliment Pharmacol Ther; 2010 Feb; 31(3):440-51. PubMed ID: 19843025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
    Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
    J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer.
    Konturek PC; Hartwich A; Zuchowicz M; Labza H; Pierzchalski P; Karczewska E; Bielanski W; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):737-49. PubMed ID: 11192946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.